Literature DB >> 12811817

The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein.

Arianna Loregian1, Katia Bortolozzo, Silvia Boso, Barbara Sapino, Monica Betti, Maria A Biasolo, Antonella Caputo, Giorgio Palú.   

Abstract

The role of Sp1 in regulating the trans-activating activity of the human immunodeficiency virus type 1 (HIV-1) Tat protein has not yet been clearly defined. In fact, studies on the physical and functional interaction between Sp1 and Tat have yielded contradictory results. Here we investigated whether a physical interaction between Sp1 and Tat indeed occurs, exploiting both biochemical and genetic techniques that allow detection of direct protein-protein interactions. Studies performed with the yeast two-hybrid system indicate that Sp1 does not directly interact with the HIV-1 Tat protein. Control experiments demonstrated that both proteins are functionally expressed in the yeast cells. In vitro binding assays further confirmed that Sp1 does not physically bind Tat. These data suggest that in vivo Tat and Sp1 most likely take part of a multicomponent complex and thus encourage the search of the molecule(s) which mediate Tat-Sp1 interaction. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12811817     DOI: 10.1002/jcp.10271

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  13 in total

1.  The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication.

Authors:  Beatrice Mercorelli; Anna Luganini; Giulia Muratore; Serena Massari; Maria Elena Terlizzi; Oriana Tabarrini; Giorgio Gribaudo; Giorgio Palù; Arianna Loregian
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

2.  Nuclear factor κB2 p52 protein has a role in antiviral immunity through IκB kinase epsilon-dependent induction of Sp1 protein and interleukin 15.

Authors:  Sarah L Doyle; Kari Ann Shirey; Anne F McGettrick; Elaine F Kenny; Susan Carpenter; Brian E Caffrey; Siobhan Gargan; Susan R Quinn; Jorge H Caamaño; Paul Moynagh; Stefanie N Vogel; Luke A O'Neill
Journal:  J Biol Chem       Date:  2013-07-19       Impact factor: 5.157

3.  The HIV-1 Tat protein has a versatile role in activating viral transcription.

Authors:  Atze T Das; Alex Harwig; Ben Berkhout
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

4.  IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation.

Authors:  Dominik Hotter; Matteo Bosso; Kasper L Jønsson; Christian Krapp; Christina M Stürzel; Atze Das; Elisabeth Littwitz-Salomon; Ben Berkhout; Alina Russ; Sabine Wittmann; Thomas Gramberg; Yue Zheng; Laura J Martins; Vicente Planelles; Martin R Jakobsen; Beatrice H Hahn; Ulf Dittmer; Daniel Sauter; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2019-06-04       Impact factor: 21.023

5.  HIV infection upregulates caveolin 1 expression to restrict virus production.

Authors:  Shanshan Lin; Xiao Mei Wang; Peter E Nadeau; Ayalew Mergia
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

6.  Promoter activation by the varicella-zoster virus major transactivator IE62 and the cellular transcription factor USF.

Authors:  Min Yang; Hua Peng; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

7.  Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation.

Authors:  Leonie A Boven; Farshid Noorbakhsh; Gerben Bouma; Ruurd van der Zee; Diana L Vargas; Carlos Pardo; Justin C McArthur; Hans S L M Nottet; Christopher Power
Journal:  J Neurovirol       Date:  2007-04       Impact factor: 2.643

8.  Chromosomal integration of LTR-flanked DNA in yeast expressing HIV-1 integrase: down regulation by RAD51.

Authors:  S Desfarges; J San Filippo; M Fournier; C Calmels; A Caumont-Sarcos; S Litvak; P Sung; V Parissi
Journal:  Nucleic Acids Res       Date:  2006-11-07       Impact factor: 16.971

9.  A microfluidic-FCS platform for investigation on the dissociation of Sp1-DNA complex by doxorubicin.

Authors:  Hsin-Chih Yeh; Christopher M Puleo; Teck Chuan Lim; Yi-Ping Ho; Paul E Giza; Ru Chih C Huang; Tza-Huei Wang
Journal:  Nucleic Acids Res       Date:  2006-11-15       Impact factor: 16.971

Review 10.  Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.

Authors:  Evelyn M Kilareski; Sonia Shah; Michael R Nonnemacher; Brian Wigdahl
Journal:  Retrovirology       Date:  2009-12-23       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.